Development of a risk prediction model for bloodstream infection in patients with fever of unknown origin

被引:3
作者
Xu, Teng [1 ,2 ]
Wu, Shi [1 ,2 ]
Li, Jingwen [1 ,2 ]
Wang, Li [1 ,2 ]
Huang, Haihui [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200040, Peoples R China
[2] Natl Hlth & Family Planning Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai 200040, Peoples R China
基金
中国国家自然科学基金;
关键词
Bloodstream infection; Fever of unknown origin; Serum inflammatory marker; Scoring system; Diagnostic performance; C-REACTIVE PROTEIN; EMERGENCY-DEPARTMENT; ADULT PATIENTS; BACTEREMIA; PROCALCITONIN; ACCURACY;
D O I
10.1186/s12967-022-03796-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Bloodstream infection (BSI) is a significant cause of mortality among patients with fever of unknown origin (FUO). Inappropriate empiric antimicrobial therapy increases difficulty in BSI diagnosis and treatment. Knowing the risk of BSI at early stage may help improve clinical outcomes and reduce antibiotic overuse. Methods We constructed a multivariate prediction model based on clinical features and serum inflammatory markers using a cohort of FUO patients over a 5-year period by Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression. ResultsAmong 712 FUO patients, BSI was confirmed in 55 patients. Five independent predictors available within 24 h after admission for BSI were identified: presence of diabetes mellitus, chills, C-reactive protein level of 50-100 mg/L, procalcitonin > 0.3 ng/mL, neutrophil percentage > 75%. A predictive score incorporating these 5 variables has adequate concordance with an area under the curve of 0.85. The model showed low positive predictive value (22.6%), but excellent negative predictive value (97.4%) for predicting the risk of BSI. The risk of BSI reduced to 2.0% in FUO patients if score < 1.5. ConclusionsA simple tool based on 5 variables is useful for timely ruling out the individuals at low risk of BSI in FUO population.
引用
收藏
页数:8
相关论文
共 28 条
[1]   Clinical Metagenomics for Bloodstream Infections: Is the Juice Worth the Squeeze? [J].
Babady, N. Esther .
CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) :246-248
[2]   Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients [J].
Bassetti, Matteo ;
Russo, Alessandro ;
Righi, Elda ;
Dolso, Elisabetta ;
Merelli, Maria ;
Cannarsa, Nicola ;
D'Aurizio, Federica ;
Sartor, Assunta ;
Curcio, Francesco .
CRITICAL CARE, 2018, 22
[3]  
Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1136/bmj.g7594, 10.1016/j.jclinepi.2014.11.010, 10.1038/bjc.2014.639, 10.1002/bjs.9736, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.7326/M14-0698]
[4]   High serum procalcitonin levels do not predict bacteremia in adult patients with acute fever [J].
Debard, AL ;
Vautrin, C ;
Pariset, C ;
Bienvenu, J ;
Monneret, G .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (06) :825-826
[5]  
Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35
[6]   Interactive visualisation for interpreting diagnostic test accuracy study results [J].
Fanshawe, Thomas R. ;
Power, Michael ;
Graziadio, Sara ;
Ordonez-Mena, Jose M. ;
Simpson, John ;
Allen, Joy .
BMJ EVIDENCE-BASED MEDICINE, 2018, 23 (01) :13-16
[7]   Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe [J].
Goto, M. ;
Al-Hasan, M. N. .
CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (06) :501-509
[8]   Fever of Unknown Origin [J].
Haidar, Ghady ;
Singh, Nina .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05) :463-477
[9]   The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis [J].
Hoeboer, S. H. ;
van der Geest, P. J. ;
Nieboer, D. ;
Groeneveld, A. B. J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (05) :474-481
[10]   Outcomes in patients with an emergency department diagnosis of fever of unknown origin [J].
Ingarfield, Sharyn L. ;
Celenza, Antonio ;
Jacobs, Ian G. ;
Riley, Thomas V. .
EMERGENCY MEDICINE AUSTRALASIA, 2007, 19 (02) :105-112